High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapies

Erstveröffentlichung
2018
Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors
Dreger, Peter
Ghia, Paolo
Schetelig, Johannes
van Gelder, Michel
Kimby, Eva
et al.
Institutions
UKU. Klinik für Innere Medizin III
Published in
Blood ; 132 (2018), 9. - S. 892-902. - ISSN 0006-4971. - eISSN 1528-0020
Link to publication
https://dx.doi.org/10.1182/blood-2018-01-826008
Funding information
Janssen
Gilead
AbbVie
Genzyme
Sanofi
etc.
Keywords
versus-host-disease; gcllsg cll3x trial; marrow transplantation; open-label; follow-up; allogeneic transplantation; clonal evolution; european-society; richter transformation; retrospective analysis
Dewey Decimal Group
DDC 610 / Medicine & health
Metadata
Show full item record